Roivant Sciences Ltd. (ROIV) Misses Q3 EPS by 7c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of ($0.38), $0.07 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $1.99 million versus the consensus estimate of $5.13 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Hologic recalls BioZorb markers after reported injuries - FDA
• Activist Jana Partners Built New Position In Tech Company Everpure , Sources Say - Reuters